StockData
CytoMed Therapeutics Ltd logo

CytoMed Therapeutics Ltd (GDTC) stock

GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 4/30
$0.78+0.01 (+1.18%)

Close on Nov 17, 2026Market cap $9.26MP/E –Yield –

CytoMed Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

CytoMed Therapeutics's enterprise value was $8.86M on Nov 11, 2026, against $18.00M a year earlier. Over the last 4 years it ranged from $6.01M to $40.79M, with a median of $20.62M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$8.86M-27.1%
2025Dec 31, 2025$12.15M-65.3%
2024Dec 31, 2024$34.97M-14.3%
2023Dec 29, 2023$40.79M–

More CytoMed Therapeutics figures

See a number that looks wrong?